עקוב אחר
Teofilo Vasconcelos
Teofilo Vasconcelos
BIAL
כתובת אימייל מאומתת בדומיין bial.com - דף הבית
כותרת
צוטט על ידי
צוטט על ידי
שנה
Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs
T Vasconcelos, B Sarmento, P Costa
Drug discovery today 12 (23-24), 1068-1075, 2007
21672007
Amorphous solid dispersions: Rational selection of a manufacturing process
T Vasconcelos, S Marques, J das Neves, B Sarmento
Advanced drug delivery reviews 100, 85-101, 2016
4292016
Gellan gum/pectin beads are safe and efficient for the targeted colonic delivery of resveratrol
FG Prezotti, FI Boni, NN Ferreira, DS Silva, SP Campana-Filho, A Almeida, ...
Polymers 10 (1), 50, 2018
622018
Oral nanoparticles based on gellan gum/pectin for colon-targeted delivery of resveratrol
FG Prezotti, FI Boni, NN Ferreira, DS Silva, A Almeida, T Vasconcelos, ...
Drug Development and Industrial Pharmacy 46 (2), 236-245, 2020
602020
Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol
T Vasconcelos, F Prezotti, F Araújo, C Lopes, A Loureiro, S Marques, ...
International Journal of Pharmaceutics 595, 120245, 2021
562021
Measuring the emulsification dynamics and stability of self-emulsifying drug delivery systems
T Vasconcelos, S Marques, B Sarmento
European Journal of Pharmaceutics and Biopharmaceutics 123, 1-8, 2018
512018
Multicomponent self nano emulsifying delivery systems of resveratrol with enhanced pharmacokinetics profile
T Vasconcelos, F Araújo, C Lopes, A Loureiro, J das Neves, S Marques, ...
European journal of pharmaceutical sciences 137, 105011, 2019
432019
The biopharmaceutical classification system of excipients
Vasconcelos, Teofilo, S Marques, bruno Sarmento
Therapeutic delivery 8 (2), 65-78, 2017
412017
Development of a rapid dissolving ibuprofen solid dispersion
T Vasconcelos, P Costa
Pharm Res 16, 676-681, 2007
372007
Pharmaceutical composition for poorly soluble drugs
TC De Vasconcelos
US Patent App. 12/920,025, 2011
222011
Dosage form proportionality and food effect of the final tablet formulation of eslicarbazepine acetate: randomized, open-label, crossover, single-centre study in healthy volunteers
C Fontes-Ribeiro, T Macedo, T Nunes, C Neta, T Vasconcelos, ...
Drugs in R & D 9, 447-454, 2008
192008
Polymer-based delivery systems for oral delivery of peptides and proteins
B Sarmento, D Ferreira, T Vasconcelos
Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic …, 2009
152009
Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
TC de Vasconcelos, RJ dos Santos Lima, PM da Costa Barrocas, ...
US Patent App. 12/750,957, 2010
14*2010
Solid dispersions as strategy to improve oral bioavailability of poorly water soluble drugs
P Costa, B Sarmento, T Vasconcelos
Drug Discov Today 12 (23-24), 1068-1075, 2009
122009
Bioequivalence of final tablet formulation and research tablet formulation of eslicarbazepine acetate in healthy volunteers
R Lima, T Vasconcelos, R Cerdeira, M Lefebvre, E Sicard
J Bioequiv Availab 1 (3), 93-98, 2009
112009
Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
TC De Vasconcelos, RJ dos Santos Lima, RCDC Costa
US Patent 10,071,085, 2018
102018
Pharmaceutical composition comprising licarbazepine acetate
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent 8,372,431, 2013
9*2013
Composition
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent App. 12/257,240, 2009
82009
Solubility enhancement as strategies to improve oral bioavailability of poorly water soluble drugs
T Vasconcelos, B Sarmento, P Costa
Drug discovery today 12, 1281-1302, 2007
82007
Cell-Based Intestinal In Vitro Models for Drug Absorption Screening
H Almeida, ACF Vieira, J Teixeira, MJ Gomes, P Barrocas, T Vasconcelos, ...
Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays, 1-22, 2022
72022
המערכת אינה יכולה לבצע את הפעולה כעת. נסה שוב מאוחר יותר.
מאמרים 1–20